Bruker Secondary Offering Priced at $9.85 | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker has priced a secondary offering of 13 million common shares at $9.85 per share.

The firm announced last week that it had filed for a secondary offering of 12 million shares of common stock by two members of the Laukien family — Marc Laukien and Isolde Laukien-Kleiner — not involved in the firm's business. Bruker will not receive any of the proceeds from the sale of shares by these two Laukien family members.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.